• Hypertension is common in the elderly and is associated with higher morbidity and mortality, which may be decreased by effective blood pressure control. Many antihypertensive drugs, however, are not well tolerated by the aged. We treated 21 patients (ten men and 11 women) between ages 65 and 84 years (mean, 73.6 years) with guanadrel sulfate. All patients had received prior antihypertensive therapy, which either was ineffective or caused undesirable side effects. Average follow-up time was 17 months. Mean systolic pressure on enrollment was 188±17 mm Hg and mean diastolic pressure was 100±10 mm Hg. After treatment, the mean systolic pressure was 139±15 mm Hg and mean diastolic pressure was 82±8 mm Hg. Dosage varied from 5 to 30 mg/d with a mean of 16 mg/d. The only significant side effects were fatigue, dizziness, and dyspnea reported in four patients. Eleven patients took the medication as monotherapy and ten received diuretics or diuretics and β-blockers as additional therapy. Our conclusion Is that guanadrel is an effective, well-tolerated medication for treatment of hypertension in the elderly.
(Arch Intern Med 1988;148:1515-1518)
Thank you for submitting a comment on this article. It will be reviewed by JAMA Internal Medicine editors. You will be notified when your comment has been published. Comments should not exceed 500 words of text and 10 references.
Do not submit personal medical questions or information that could identify a specific patient, questions about a particular case, or general inquiries to an author. Only content that has not been published, posted, or submitted elsewhere should be submitted. By submitting this Comment, you and any coauthors transfer copyright to the journal if your Comment is posted.
* = Required Field
Disclosure of Any Conflicts of Interest*
Indicate all relevant conflicts of interest of each author below, including all relevant financial interests, activities, and relationships within the past 3 years including, but not limited to, employment, affiliation, grants or funding, consultancies, honoraria or payment, speakers’ bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. If all authors have none, check "No potential conflicts or relevant financial interests" in the box below. Please also indicate any funding received in support of this work. The information will be posted with your response.
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 1
Customize your page view by dragging & repositioning the boxes below.
More Listings atJAMACareerCenter.com >
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.